These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 23168697)

  • 1. Oncolytic viruses & their specific targeting to tumour cells.
    Singh PK; Doley J; Kumar GR; Sahoo AP; Tiwari AK
    Indian J Med Res; 2012 Oct; 136(4):571-84. PubMed ID: 23168697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses.
    Goradel NH; Alizadeh A; Hosseinzadeh S; Taghipour M; Ghesmati Z; Arashkia A; Negahdari B
    Future Oncol; 2022 Jan; 18(2):245-259. PubMed ID: 34821517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical development directions in oncolytic viral therapy.
    Eager RM; Nemunaitis J
    Cancer Gene Ther; 2011 May; 18(5):305-17. PubMed ID: 21436867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic Virotherapy by HSV.
    Watanabe D; Goshima F
    Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization and preclinical design of genetically engineered viruses for human oncolytic therapy.
    Hiss DC; Fielding BC
    Expert Opin Biol Ther; 2012 Nov; 12(11):1427-47. PubMed ID: 22788715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic Viruses in Cancer Treatment: A Review.
    Lawler SE; Speranza MC; Cho CF; Chiocca EA
    JAMA Oncol; 2017 Jun; 3(6):841-849. PubMed ID: 27441411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiating oncolytic viruses by targeted drug intervention.
    Mahoney DJ; Stojdl DF
    Curr Opin Mol Ther; 2010 Aug; 12(4):394-402. PubMed ID: 20677090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SnapShot: Cancer Immunotherapy with Oncolytic Viruses.
    Gujar S; Bell J; Diallo JS
    Cell; 2019 Feb; 176(5):1240-1240.e1. PubMed ID: 30794777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy.
    Chowaniec H; Ślubowska A; Mroczek M; Borowczyk M; Braszka M; Dworacki G; Dobosz P; Wichtowski M
    Front Immunol; 2024; 15():1375433. PubMed ID: 38576614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newcastle disease virus as an oncolytic agent.
    Ravindra PV; Tiwari AK; Sharma B; Chauhan RS
    Indian J Med Res; 2009 Nov; 130(5):507-13. PubMed ID: 20090097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.
    Park GT; Choi KC
    Oncotarget; 2016 Sep; 7(36):58684-58695. PubMed ID: 27494901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer.
    Ilkow CS; Swift SL; Bell JC; Diallo JS
    PLoS Pathog; 2014 Jan; 10(1):e1003836. PubMed ID: 24453963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering strategies to enhance oncolytic viruses in cancer immunotherapy.
    Tian Y; Xie D; Yang L
    Signal Transduct Target Ther; 2022 Apr; 7(1):117. PubMed ID: 35387984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy progress and prospects cancer: oncolytic viruses.
    Liu TC; Kirn D
    Gene Ther; 2008 Jun; 15(12):877-84. PubMed ID: 18418413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double trouble for tumours: exploiting the tumour microenvironment to enhance anticancer effect of oncolytic viruses.
    De Silva N; Atkins H; Kirn DH; Bell JC; Breitbach CJ
    Cytokine Growth Factor Rev; 2010; 21(2-3):135-41. PubMed ID: 20338801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translation of targeted oncolytic virotherapeutics from the lab into the clinic, and back again: a high-value iterative loop.
    Liu TC; Hwang TH; Bell JC; Kirn DH
    Mol Ther; 2008 Jun; 16(6):1006-8. PubMed ID: 18500240
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeting pediatric cancer stem cells with oncolytic virotherapy.
    Friedman GK; Cassady KA; Beierle EA; Markert JM; Gillespie GY
    Pediatr Res; 2012 Apr; 71(4 Pt 2):500-10. PubMed ID: 22430386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic viruses: overcoming translational challenges.
    Martinez-Quintanilla J; Seah I; Chua M; Shah K
    J Clin Invest; 2019 Mar; 129(4):1407-1418. PubMed ID: 30829653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redirecting oncolytic viruses: Engineering opportunists to take control of the tumour microenvironment.
    Jamieson TR; Poutou J; Ilkow CS
    Cytokine Growth Factor Rev; 2020 Dec; 56():102-114. PubMed ID: 32958389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.